01
We’re with you,
together.
Developing breakthrough medicines for
global unmet healthcare needs
Think innovative,
Move to patient’s
centric

Neurobiogen is focusing on R&D with the main goal of developing innovative new drugs to treat global unmet diseases (neurodegenerative brain disease and metabolic disease).

With our new drug candidate Tisolagiline(KDS2010),
we intend to grow into a global company that contributes to improving human health.